Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block
- Conditions
- Pain, PostoperativeHip Dysplasia
- Interventions
- Registration Number
- NCT05543109
- Lead Sponsor
- Tanta University
- Brief Summary
The aim of this study was to compare the intraoperative and the postoperative analgesic effect of psoas compartment block (PCB) and supra-inguinal fascia iliaca compartment block (SFIB) in pediatric patients undergoing developmental dysplasia of the hip
- Detailed Description
All subjects after entering operation room will be connected to standard monitor electrocardiograph, non-invasive blood pressure, heart rate, oxygen saturation.
Three mg/kg of propofol, 0.2 μg/kg of fentanyl and 0.1 mg/kg midazolam will be used for sedation. Oxygen at the concentration of 100% will be administrated under the mask in all patients after satisfactory sedation, tracheal intubation will be performed after intravenous anesthesia with administration of 3 mg/kg of propofol, 0.6 μg/kg of fentanyl and 0.9 mg/kg of rocurium. After intubation 2-3% of sevoflurane and 0.2-0.3 mcg/kg/min of fentanyl will be used to maintain anesthesia guided by PSI and hemodynamic monitoring.
The two groups will receive nerve block with local anesthetics. In the SFIB group, the patients will receive ultrasound-guided SFIB, while the patients in the PCB group will receive PCB under the guidance of ultrasound.
Local anesthetic 0.25% Ropivacaine will be used at 1 ml/kg for SFIB and PCB. (the dose of local anesthetic for SFIB or PCB was not more than 35ml). All blocks will be performed by the same experienced anesthesiologist.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 85
- Patients undergoing undergo acetabuloplasty
- Anesthesiologists (ASA) physical status of I to II
- Known allergy to local anesthetic
- Infection at the block site.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Psoas compartment block Fentanyl After induction of anesthesia; ultrasound guided psoas compartment block will be done using ropivacaine 0.25% 1ml/kg. Suprainguinal fascia iliaca compartment block Fentanyl After induction of anesthesia; ultrasound guided suprainguinal fascia iliaca compartment block will be done using ropivacaine 0.25% 1ml/kg. Psoas compartment block Propofol After induction of anesthesia; ultrasound guided psoas compartment block will be done using ropivacaine 0.25% 1ml/kg. Psoas compartment block Ropivacaine After induction of anesthesia; ultrasound guided psoas compartment block will be done using ropivacaine 0.25% 1ml/kg. Psoas compartment block Rocuronium After induction of anesthesia; ultrasound guided psoas compartment block will be done using ropivacaine 0.25% 1ml/kg. Psoas compartment block Sevoflurane After induction of anesthesia; ultrasound guided psoas compartment block will be done using ropivacaine 0.25% 1ml/kg. Suprainguinal fascia iliaca compartment block Propofol After induction of anesthesia; ultrasound guided suprainguinal fascia iliaca compartment block will be done using ropivacaine 0.25% 1ml/kg. Suprainguinal fascia iliaca compartment block Rocuronium After induction of anesthesia; ultrasound guided suprainguinal fascia iliaca compartment block will be done using ropivacaine 0.25% 1ml/kg. Suprainguinal fascia iliaca compartment block Sevoflurane After induction of anesthesia; ultrasound guided suprainguinal fascia iliaca compartment block will be done using ropivacaine 0.25% 1ml/kg. Suprainguinal fascia iliaca compartment block Ropivacaine After induction of anesthesia; ultrasound guided suprainguinal fascia iliaca compartment block will be done using ropivacaine 0.25% 1ml/kg.
- Primary Outcome Measures
Name Time Method Postoperative analgesic requirements 8 hours Postoperative Ketoprofen and morphine consumption
Intraoperative anesthetic requirement 1 hour Intraoperative anesthetic requirement including intraoperative sevoflurane concentration and total fentanyl consumption
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mona Mohamed Mogahed
🇪🇬Tanta, Elgharbia, Egypt